期刊文献+

SP2/0细胞膜抗原负载DC诱导体外特异性CTL效应 被引量:2

Induction of specific cytotoxity T lymphocyte response by dendritic cells pulsed with SP2/0 cellular membrane antigen in vitro
下载PDF
导出
摘要 目的研究SP2/0细胞膜抗原负载树突状细胞(DC)诱导的特异性细胞毒性T淋巴细胞(CTL)对肿瘤细胞的杀伤活性。方法密度梯度离心法分离SP2/0细胞膜,负载经rmGM-CSF和rmIL-4诱导扩增的小鼠骨髓来源的DC,活化T淋巴细胞获得肿瘤特异性CTL,MTT法检测对SP2/0细胞的杀伤效果。结果骨髓单个核细胞在rmGM-CSF和rmIL-4作用下获得了高表达CD80、CD86和MHC-Ⅱ分子的DC,致敏的CTL对SP2/0骨髓瘤细胞具有高杀伤率,显著高于对L5178Y淋巴瘤细胞的杀伤活性(P<0.01)。结论SP2/0细胞膜抗原负载DC能诱导明显的特异性抗肿瘤免疫应答。 Objective To investigate the cytotoxic efficiency of tumor specific cytotoxic T lymphocyte (CTL) induced by SP2/0 cellular membrane antigen-loaded syngeneic dendritic cells (DC). Methods SP2/0 cellular membrane was obtained by density gradient centrifugation. Bone marrow-derived DC Balb/c of inbred mouse hne was generated in vitro in the presence of granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin-4 (IL-4). The tumor-specific CTL was induced by membrane antigen-loaded DC. The cytotoxicity of CTL was assayed by MTT. Mouse lymphoma cell line L5178Y was used as control in this experiment. Results In the presence of GM-CSF and IL-4, the bone marrow precursors of Balb/c mouse generated DCs that highly expressed major-histocompatibility-complex class Ⅱ (MHC- Ⅱ ) and costimulating molecules CD80 and CD86. CTLs induced with SP2/0 cellular membrane antigen-loaded DCs had strong tumor-specific cytotoxicity to SP2/0 cells, especially at the high effector/target ratio. These CTLs had very low cytotoxic effects to L5178Y lymphoma cells compared with SP2/0 cells ( P 〈 0.01). Conclusion SP2/0 cellular membrane antigen-loaded DC can elicit potent specific antitumor immune response in vitro.
出处 《免疫学杂志》 CAS CSCD 北大核心 2006年第1期51-53,共3页 Immunological Journal
关键词 树突状细胞 细胞毒性T淋巴细胞 骨髓瘤 细胞膜 Dendritic cell Cytotoxic T lymphocyte Myeloma Cellular membrane
  • 相关文献

参考文献4

二级参考文献18

  • 1范建高,曾民德,江绍基,朱菊人,刘占峰,赵洪涛,陆伟君.肝癌患者血浆PGE_2含量与T细胞亚群和NK细胞活性的关系[J].上海免疫学杂志,1995,15(5):298-300. 被引量:9
  • 2[1]Corwin LM, Humphrey LP, Shloss J. Effect of lipids on the expression of cell transformation [J]. Exp Cell Res, 1977,108 (2): 341 - 347.
  • 3[2]Jett M, Seed TM, Jamieson GA. Isolation and characterization of plasma membranes and intact nuclei from lymphoid cells [J]. J Biol Chem, 1977, 252 (6): 2 134- 2 142.
  • 4[3]Inaha K, Inaba M, Romani N, et al. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor [J]. J Exp Med, 1992, 176 (6): 1 693 - 1 702.
  • 5[5]Harder T, Simons K. Caveolae, DIGs, and the dynamics of sphingolipid-cholesterol microdomains [J]. Curr Opin Cell Biol, 1997, 9 (4): 534-542.
  • 6[6]Sloan AE, Parajuli P. Human autologous dendritic cell-glioma fusions: feasibility and capacity to stimulate T cells with proliferative and cytolytic activity [ J]. J Neurooncol, 2003,64 (1/2): 177 - 183.
  • 7[7]Galea-Lauri J, Darling D, Mufti G, et al. Eliciting cytotoxic T lymphocytes against acute myeloid leukemia-derived antigens: evaluation of dendritic cell-leukemia cell hybrids and other antigen-loading strategies for dendritic cell-based vaccination [ J ]. Cancer Immunol Immunother, 2002, 51 (6):299 - 310.
  • 8[8]Albert ML, Pearce SF, Francisco LM, et al. Immature dendritic cells phagocytose apoptotic cells via alphavbeta 5 and CD36, and cross-present antigens to cytotoxic T lymphocytes[J]. J Exp Med, 1998, 188 (7): 1 359- 1 368.
  • 9王晓林 沈关心 周汝麟主编.免疫细胞的分离与功能检测[A].沈关心,周汝麟主编.现代免疫学实验技术[C].湖北:湖北科学技术出版社,1998.309-310.
  • 10韩树桐 武永吉.多发性骨髓瘤[A].张之南主编.血液病诊断及疗效标准:第2版[C].北京:科学出版社,1998.373-380.

共引文献12

同被引文献13

  • 1殷月兰,焦新安,潘志明,张晓明,顾志强,陈瑶.李斯特菌溶血素基因的原核表达及其生物学特性[J].微生物学报,2004,44(6):752-755. 被引量:17
  • 2金冬雁 黎孟枫 侯云德 译.分子克隆实验指南[M](第2版)[M].北京:科学出版社,1992.16-57.
  • 3Liau LM,Prins RM,Kiertscher SM,et al.Dendritic cell vaccination in glioblastoma patients induces systemic and intracranial T-cell responses modulated by the local central nervous system tumor microenvironment[J].Clin Cancer Res,2005,11(15):5 515-5 525.
  • 4van den Broeke LT,Daschbach E,Thomas EK,et al.Dendritic cell-induced activation of adaptive and innate antitumor immunity[J].J Immunol,2003,171 (11):5 842-5 852.
  • 5Yamanaka R,Homma J,Yajima N,et al.Clinical eva -luation of dendritic cell vaccination for patients with recurrent glioma:results of a clinical phase Ⅰ/Ⅱ trial[J].Clin Cancer Res,2005,11(11):4 160-4 167.
  • 6Zhu X,Lu C,Xiao B,et al.An experimental study of dendritic cells-mediated immnnotherapy against intracranial gliomas in rats[J].J Neurooncol,2005,74(1):9-17.
  • 7Chaput N,Schartz NE,Andre F,et al.Exosomes as potent cell-free peptide-based vaccine.Ⅱ.Exosomes in CpG adjuvants efficiently prime naive Tcl lymphocytes leading to tumor rejection[J].J Immunol,2004,172 (4):2 137-2 146.
  • 8Driessens G,Hamdane M,Cool V,et al.Highly successful therapeutic vaccinations combining dendritic cells and tumor cells secreting granulocyte macrophage colony-stimulating factor[J].Cancer Res,2004,64(22):8 435-8 442.
  • 9Chaput N,Taieb J,Schartz NE,et al.Exosome-based immunotherapy[J].Cancer Immnnol Immunother,2004,53 (3):243-249.
  • 10Bossuyt X,Marti GE,Fleisher TA.Comparative analysis of whole blood lysis methods for flow cytometry[J].Cytometry (Communications in Clinical Cytometry),1997,30:124-133.

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部